BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30044345)

  • 1. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.
    Kohli S; Rastogi N; Nivargi S; Thakkar D; Katewa S; Yadav SP
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e158-e160. PubMed ID: 30044345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
    Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
    Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
    Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Li Z; Wang Y; Wang J; Zhang J; Wang Z
    Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
    Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.
    Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
    Vellaichamy Swaminathan V; Ravichandran N; Ramanan KM; Meena SK; Varla H; Ramakrishnan B; Jayakumar I; Uppuluri R; Raj R
    Pediatr Transplant; 2021 Mar; 25(2):e13893. PubMed ID: 33111490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.
    Sanz J; Galimard JE; Labopin M; Afanasyev B; Angelucci E; Ciceri F; Blaise D; Cornelissen JJ; Meijer E; Diez-Martin JL; Koc Y; Rovira M; Castagna L; Savani B; Ruggeri A; Nagler A; Mohty M;
    J Hematol Oncol; 2020 May; 13(1):46. PubMed ID: 32375860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
    Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
    J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Reduced Intensity Conditioning Alternate Donor Stem Cell Transplant for Wiskott-Aldrich Syndrome.
    Thakkar D; Katewa S; Rastogi N; Kohli S; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e493-e496. PubMed ID: 28859032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.
    Sugita J
    Int J Hematol; 2019 Jul; 110(1):30-38. PubMed ID: 31104211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome].
    Sun R; Xiao J; Zhang J; Lu Y; Wei Z; Zhu H; Sun Y
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):94-8. PubMed ID: 24739718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide and Antithymocyte Globulin from HLA-Mismatched Related Donors for Nonmalignant Diseases.
    Osumi T; Yoshimura S; Sako M; Uchiyama T; Ishikawa T; Kawai T; Inoue E; Takimoto T; Takeuchi I; Yamada M; Sakamoto K; Yoshida K; Kimura Y; Matsukawa Y; Matsumoto K; Imadome KI; Arai K; Deguchi T; Imai K; Yuza Y; Matsumoto K; Onodera M; Kanegane H; Tomizawa D; Kato M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):e286-e291. PubMed ID: 32798657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Messina C; Zecca M; Fagioli F; Rovelli A; Giardino S; Merli P; Porta F; Aricò M; Sieni E; Basso G; Ripaldi M; Favre C; Pillon M; Marzollo A; Rabusin M; Cesaro S; Algeri M; Caniglia M; Di Bartolomeo P; Ziino O; Saglio F; Prete A; Locatelli F
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1223-1231. PubMed ID: 29410181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient.
    Ayala E; LaFave D; Nishihori T; Kharfan-Dabaja MA
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):96-98. PubMed ID: 27352259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
    Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
    Neven B; Diana JS; Castelle M; Magnani A; Rosain J; Touzot F; Moreira B; Fremond ML; Briand C; Bendavid M; Levy R; Morelle G; Vincent M; Magrin E; Bourget P; Chatenoud L; Picard C; Fischer A; Moshous D; Blanche S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1363-1373. PubMed ID: 30876929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.